Skip to main content
Premium Trial:

Request an Annual Quote

The Automation Partnership to Manufacture Cellectricon's Ion Channel Screening Platform

NEW YORK (GenomeWeb News) – Cellectricon said today that the Automation Partnership will co-develop and manufacture Cellectricon’s DynaflowHT System, a high-throughput ion channel screening platform that the company plans to launch next year.
 
Cellectricon has been developing the Dynaflow HT platform, a cell-based microfluidics electrophysiology system, over the last three years in partnership with AstraZeneca.
 
Financial terms of the agreement with TAP were not disclosed.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.